Slingshot members are tracking this event:

ZURAMPIC (lesinurad) approved by US FDA for patients with gout

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 22, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Zurampic, Lesinurad, Xanthine Oxidase Inhibitor, Xoi, Hyperuricemia, Gout, Allopurinol, Febuxostat, Fda, Approval, Clear, Crystal